Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Cellular and Molecular Mechanisms of Sensitivity and Resistance of Hematopoietic Malignant Cells to Treatment with ch128.1Av, An Antibody-Avidin Fusion Protein Specific for Human Transferrin Receptor 1 (CD71).

Jose A Rodriguez, Gustavo Helguera, PhD, Tracy R Daniels, Ph.D., David Casero Diaz-Cano, Ph.D., Elizabeth Ortiz-Sanchez, PhD, Giovanni Coppola, Ph.D., Matteo Pellegrini, Ph.D., Otoniel Martinez-Maza, Ph.D., Manuel L Penichet, M.D., Ph.D.

Blood (2008) 112 (11): 1608.

https://doi.org/10.1182/blood.V112.11.1608.1608

Published: 2008

Journal Articles

Inhibition of the Akt Pathway in MM Cell Lines by the Anti-TfR-IgG3-Avidin Fusion Protein (Anti-TfR-IgG3-Av): Role in Chemosensitization to CDDP-Induced Apoptosis

Eriko Suzuki, Ph.D., Kazuo Umezawa, Ph.D., Gustavo Helguera, PhD, Tracy R Daniels, Ph.D., Gary Schiller, James R. Berenson, MD, Manuel L Penichet, M.D., Ph.D., Benjamin Bonavida, PhD

Blood (2008) 112 (11): 4473.

https://doi.org/10.1182/blood.V112.11.4473.4473

Published: 2008

Journal Articles

Identification of Differentially Expressed Genes in the Rituximab- Resistant Clone (Ramos RR1) Compared to Wildtype Sensitive Ramos: Therapeutic Implications in Rituximab-Resistance

Stavroula Baritaki, PhD, Jose Rodriguez, Gustavo Helguera, PhD, Melisa Martinez-Paniagua, Mario Vega, PhD, Sara Huerta-Yepez, PhD., Ali Jazirehi, PhD, Demetrios Spandidos, PhD, Manuel L Penichet, M.D., Ph.D., Benjamin Bonavida, PhD

Blood (2008) 112 (11): 3770.

https://doi.org/10.1182/blood.V112.11.3770.3770

Published: 2008

Journal Articles

The Role of Iron in the Cytotoxicity Induced in Hematopoietic Malignant Cell Lines by an Anti-Transferrin Receptor IgG3-Avidin Fusion Protein and Gambogic Acid.

Elizabeth Ortiz-Sanchez, PhD, Tracy R. Daniels, Ph.D., Gustavo Helguera, Ph.D., Otoniel Martinez-Maza, Ph.D., Benjamin Bonavida, Ph.D., Manuel L. Penichet, M.D., Ph.D.

Blood (2007) 110 (11): 4204.

https://doi.org/10.1182/blood.V110.11.4204.4204

Published: 2007

Journal Articles

Insights into the Genetic Signature Associated with Cell Death Induced by an Antibody-Avidin Fusion Protein Specific for Transferrin Receptor.

Gustavo Helguera, PhD, Jose A. Rodriguez, Tracy R. Daniels, PhD, David Casero Diaz-Cano, PhD, Matteo Pellegrini, PhD, Manuel L. Penichet, MD, PhD

Blood (2007) 110 (11): 3476.

https://doi.org/10.1182/blood.V110.11.3476.3476

Published: 2007

Journal Articles

Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor

Patrick P. Ng, Gustavo Helguera, Tracy R. Daniels, Simon Z. Lomas, Jose A. Rodriguez, Gary Schiller, Benjamin Bonavida, Sherie L. Morrison, Manuel L. Penichet

Blood (2006) 108 (8): 2745–2754.

https://doi.org/10.1182/blood-2006-04-020263

Published: 2006

Includes: Supplemental data

Journal Articles

Chemosensitization of CDDP-Resistant Multiple Myeloma Cell Lines Following Treatment with Anti-TfR IgG3-Av.

Eriko Suzuki, Xiao-Ho Gan, MD, Kazuo Umezawa, PhD, Gustavo Helguera, PhD, Gary Schiller, MD, Manuel Penichet, MD, PhD, Benjamin Bonavida, PhD

Blood (2005) 106 (11): 5119.

https://doi.org/10.1182/blood.V106.11.5119.5119

Published: 2005

NARROW

Cellular and Molecular Mechanisms of Sensitivity and Resistance of Hematopoietic Malignant Cells to Treatment with ch128.1Av, An Antibody-Avidin Fusion Protein Specific for Human Transferrin Receptor 1 (CD71).

Inhibition of the Akt Pathway in MM Cell Lines by the Anti-TfR-IgG3-Avidin Fusion Protein (Anti-TfR-IgG3-Av): Role in Chemosensitization to CDDP-Induced Apoptosis

Identification of Differentially Expressed Genes in the Rituximab- Resistant Clone (Ramos RR1) Compared to Wildtype Sensitive Ramos: Therapeutic Implications in Rituximab-Resistance

The Role of Iron in the Cytotoxicity Induced in Hematopoietic Malignant Cell Lines by an Anti-Transferrin Receptor IgG3-Avidin Fusion Protein and Gambogic Acid.

Insights into the Genetic Signature Associated with Cell Death Induced by an Antibody-Avidin Fusion Protein Specific for Transferrin Receptor.

Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor

Chemosensitization of CDDP-Resistant Multiple Myeloma Cell Lines Following Treatment with Anti-TfR IgG3-Av.

Email alerts

ASH Publications

American Society of Hematology

Cellular and Molecular Mechanisms of Sensitivity and Resistance of Hematopoietic Malignant Cells to Treatment with ch128.1Av, An Antibody-Avidin Fusion Protein Specific for Human Transferrin Receptor 1 (CD71).

Inhibition of the Akt Pathway in MM Cell Lines by the Anti-TfR-IgG3-Avidin Fusion Protein (Anti-TfR-IgG3-Av): Role in Chemosensitization to CDDP-Induced Apoptosis

Identification of Differentially Expressed Genes in the Rituximab- Resistant Clone (Ramos RR1) Compared to Wildtype Sensitive Ramos: Therapeutic Implications in Rituximab-Resistance

The Role of Iron in the Cytotoxicity Induced in Hematopoietic Malignant Cell Lines by an Anti-Transferrin Receptor IgG3-Avidin Fusion Protein and Gambogic Acid.

Insights into the Genetic Signature Associated with Cell Death Induced by an Antibody-Avidin Fusion Protein Specific for Transferrin Receptor.

Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor

Chemosensitization of CDDP-Resistant Multiple Myeloma Cell Lines Following Treatment with Anti-TfR IgG3-Av.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only